You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hürthle Cell Carcinoma and Follicular Thyroid Carcinoma

Completed
  • Huerthle Cell Carcinoma
    • (no location specified)
    Jul 20, 2023

    Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

    Recruiting
    • Squamous Cell Carcinoma of Oral Cavity
    • +3 more
    • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
    • Gliwice, Silesia, Poland
      The Maria Sklodowska-Curie National Research Institute of Oncolo
    Aug 7, 2023

    Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • KSD-101
    • Wuhan, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 19, 2023

    Delving Into Participation Trends in Renal Cell Carcinoma

    Not yet recruiting
    • Renal Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Oct 16, 2023

      Merkel Cell Carcinoma Clinical Trial Engagement Patterns

      Not yet recruiting
      • Merkel Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Sep 8, 2023

        Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

        Not yet recruiting
        • Squamous Cell Carcinoma of the Skin
        • +2 more
        • Marlborough, Massachusetts
          Phio Pharmaceuticals Corp.
        Aug 25, 2023

        Pancreatic Adenocarcinoma, Adenosquamous Carcinoma, Pancreatic Neuroendocrine Tumor Trial (ESK981)

        Not yet recruiting
        • Pancreatic Adenocarcinoma
        • +6 more
        • (no location specified)
        Aug 4, 2023

        Nasopharyngeal Carcinoma Trial in Hangzhou (Endostar and Envafolimab)

        Recruiting
        • Nasopharyngeal Carcinoma
        • Endostar and Envafolimab
        • Hangzhou, Zhejiang, China
          Zhejiang Cancer Hospital
        Sep 24, 2023

        Hepatocellular Carcinoma Trial in Yerevan

        Recruiting
        • Hepatocellular Carcinoma
          • Yerevan, Armenia
            Nikomed Medical Center
          Jun 28, 2023

          Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

          Recruiting
          • Hepatocellular Carcinoma
          • Seoul, Korea, Republic of
            Asan Medical Center
          Nov 14, 2023

          Resectable Hepatocellular Carcinoma Trial in Jakarta Pusat (Liver Resection)

          Completed
          • Resectable Hepatocellular Carcinoma
          • Liver Resection
          • Jakarta Pusat, DKI Jakarta, Indonesia
            Dr. Cipto Mangunkusumo General Hospital
          Aug 24, 2023

          Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

          Not yet recruiting
          • Advanced Esophageal Squamous Carcinoma With Oligometastases
          • simultaneous with radiotherapy
          • synchronous with radiotherapy
          • (no location specified)
          Nov 16, 2023

          Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • no intervention
          • Wuhan, Hubei, China
            Renmin hosptial of Wuhan University
          Jul 29, 2023

          Advanced Hepatocellular Carcinoma Trial (CD-801)

          Not yet recruiting
          • Advanced Hepatocellular Carcinoma
          • (no location specified)
          Oct 13, 2023

          Immunotherapy in Upper Tract Urothelial Carcinoma

          Not yet recruiting
          • Urothelial Carcinoma
          • Evaluation of anti-PD-(L)1 immunotherapy efficacy
          • (no location specified)
          Oct 27, 2023

          Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

          Not yet recruiting
          • Esophageal Squamous Cell Carcinoma
          • Shanghai, Shanghai, China
            Fudan University Shanghai Cancer Center
          Nov 30, 2023

          Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

          Recruiting
          • Esophageal Squamous Cell Carcinoma
            • Shijiazhuang, Hebei, China
              Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
            Oct 25, 2023

            Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

            Not yet recruiting
            • Squamous Cell Carcinoma
              • San Francisco, California
                Power Life Sciences
              Jun 23, 2023

              Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

              Recruiting
              • Esophageal Squamous Cell Carcinoma
              • Head and Neck Squamous Cell Carcinoma
              • Chengdu, Sichuan, China
                West China Hospital, Sichuan University
              Oct 25, 2023

              Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)

              Recruiting
              • Liver Carcinoma
              • Hepatic Cell Carcinoma
              • CAR-GPC3 T cells
              • Wuhan, Hubei, China
                Tao Zhang
              Nov 20, 2023

              Cirrhosis, Liver Trial (Epigallocatechin gallate (EGCG), Placebo)

              Not yet recruiting
              • Cirrhosis, Liver
              • Epigallocatechin gallate (EGCG)
              • Placebo
              • (no location specified)
              Aug 27, 2023

              Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

              Recruiting
              • Metastatic Esophageal Squamous Cell Carcinoma
              • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
              • Qingdao, Shandong, China
              • +1 more
              Nov 13, 2023

              Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

              Recruiting
              • Unresectable Hepatocellular Carcinoma
              • Yttrium-90 carbon microspheres SIRT
              • Nanjing, China
                Gao-Jun Teng
              Jul 20, 2023

              Process for Hepatocellular Carcinoma

              Not yet recruiting
              • Hepatocellular Carcinoma
                • (no location specified)
                May 5, 2023

                Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

                Not yet recruiting
                • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
                • Guangzhou, Guangdong, China
                  Sun Yat-sen University
                Oct 24, 2023